W2O, an independent network of analytics, marketing and communications firms, has appointed Rita Glaze as its new practice leader of value, pricing and market access.
The new role aims to strengthen the group’s healthcare commercialisation offering and together with the practice’s founder Brian Reid, Glaze will build a multi-dimensional team to help clients with pricing and reimbursement strategy and communications.
She said: “I am thrilled to have joined W2O and look forward to working with Brian and the team to build this practice.
“We have the opportunity, through an analytics-driven approach, to work closely with pharmaceutical and biotech companies to align commercial objectives with the pricing and value realities within their markets.”
Glaze has 25 years’ experience in the biopharmaceutical and life science sector with expertise in marketing, managed markets, pricing strategy and communications.
She has held senior positions with organisations such as Takeda, Allscripts, Searle/Pharmacia.
Joining the network from Edelman, Glaze previously led the design and implementation of its US market access communications offering.